TP73 and colorectal carcinoma: We (29) and others (30, 37) have shown that p53-targeted pathways can be restored in p53-null or -mutated CRC cells through stimulating p73 activity, as there is a substantial redundancy in the tumor suppressive functions of these two proteins (31).